Success Metrics

Clinical Success Rate
100.0%

Based on 14 completed trials

Completion Rate
100%(14/14)
Active Trials
5(24%)
Results Posted
21%(3 trials)

Phase Distribution

Ph phase_2
3
14%
Ph not_applicable
13
62%
Ph phase_1
5
24%

Phase Distribution

5

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution21 total trials
Phase 1Safety & dosage
5(23.8%)
Phase 2Efficacy & side effects
3(14.3%)
N/ANon-phased studies
13(61.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

14 of 14 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

21

all time

Status Distribution
Active(5)
Completed(14)
Other(2)

Detailed Status

Completed14
Active, not recruiting4
unknown2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
5
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 15 (23.8%)
Phase 23 (14.3%)
N/A13 (61.9%)

Trials by Status

unknown210%
active_not_recruiting419%
completed1467%
recruiting15%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT07311148Phase 2

A Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine (CHO Cell), LYB004 in Adults Aged 40 Years and Older

Active Not Recruiting
NCT07035054Phase 2

Phase Ⅱ Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine

Completed
NCT07017296Not Applicable

Microencapsulated Pomegranate Juice as Anti-Hypertensive

Completed
NCT06874842Phase 1

Safety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older

Recruiting
NCT06442241Phase 1

A Safety and Immunogenicity Trial of a Respiratory Syncytial Virus Vaccine, LYB005 in Healthy Adults

Active Not Recruiting
NCT05636436Phase 1

Safety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years and Above

Active Not Recruiting
NCT05856084Phase 2

Immunogenicity and Safety of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 30 Years and Above

Active Not Recruiting
NCT06579456Not Applicable

Evaluation in a Multimodal Structured Curriculum of Laparoscopic Surgery

Completed
NCT06125912Not Applicable

A Comparative Split-Face Study of the Effects of a Retinol Alternative Cream on Improving Facial Skin Aging

Completed
NCT06063239Not Applicable

Probiotics in Special Needs Patients at High Risk for Tooth Decay: a Randomized Controlled Trial.

Unknown
NCT06063226Not Applicable

Clinical and Microbiological Aspects of Probiotics in Non-surgical Periodontal Therapy.

Unknown
NCT04510376Not Applicable

Allergy Potential of Omeza Collagen Matrix in Human Subjects Using the Skin Prick Method

Completed
NCT02553382Not Applicable

Fibre Grain Herb Trial in Type 2 Diabetes

Completed
NCT03119688Not Applicable

To Assess the Mildness of a Cosmetic Cleanser in Healthy Participants Using the Forearm-Controlled Application Technique (FCAT)

Completed
NCT03301870Phase 1

A Study to Evaluate the Irritation Potential of ATx201 in Healthy Volunteers

Completed
NCT02856880Not Applicable

A Study to Investigate the Antimicrobial Activity of 2 Test Toothpastes

Completed
NCT01984775Phase 1

A Study to Evaluate the Irritation Potential of GSK2894512 Cream on Skin in Healthy Subjects

Completed
NCT01945970Not Applicable

Effect of Black Tea on Vascular Function

Completed
NCT02518295Not Applicable

β-galactosidase Producing Probiotic Strains to Improve Lactose Digestion

Completed
NCT02792595Not Applicable

In Vivo Sun Protection Factor Determination

Completed

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
21